TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
about
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapyEarly antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives?Fuzeon-induced collagenophagic granuloma: a peculiar granulomatous injection site reaction to Fuzeon--a case report and review of literature.Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelines.Enfuvirtide: from basic investigations to current clinical use.Antiretroviral therapy: effects on orofacial health and health care.Enfuvirtide antiretroviral therapy in HIV-1 infection.Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.
P2860
Q28478894-BD533E39-D5E4-44BF-97B2-7C237F75F490Q35244295-BCDCF2AC-A0E3-4590-9070-571A0397E133Q35610449-4CD82CBB-68D1-42AA-9D93-4A6FF6AF7ADFQ37122841-E0E04E1A-AE7B-4B6E-B418-3B0C8E1447F7Q37395228-A036B7D4-268C-47A8-BBF3-F65E4D6DC66DQ37405336-F4DFF382-3A47-47D7-BA51-513ED5E72363Q37803237-96D6D056-8D27-4670-A5C0-5C2239C8EC27Q38093238-71CB5B1E-A242-4BA4-995B-1E5EB008DEC5Q41715047-511DA53F-9A6D-49F6-98BE-79FAC50477CEQ42211665-65E79D62-B8FB-487B-AFB6-6F20B693B5BBQ43282351-0699F09D-3E23-49AD-9F80-04C28F860B33
P2860
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
TORO: ninety-six-week virologi ...... background of antiretrovirals.
@en
type
label
TORO: ninety-six-week virologi ...... background of antiretrovirals.
@en
prefLabel
TORO: ninety-six-week virologi ...... background of antiretrovirals.
@en
P2093
P50
P356
P1476
TORO: ninety-six-week virologi ...... background of antiretrovirals.
@en
P2093
Adeline Valentine
Benoit Trottier
Calvin Cohen
Daniel R Kuritzkes
David A Cooper
Denise Guimaraes
Hans-Jürgen Stellbrink
Jacob P Lalezari
Jacques Reynes
Jain Chung
P304
P356
10.1089/APC.2006.0174
P50
P577
2007-08-01T00:00:00Z